Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients-Reference-Cited by-同舟云学术

Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients

Published:2004-08 Issue:4 Volume:94 Page:479-481
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Baer Jefferson T.,Sauer William H.,Berlin Jesse A.,Kimmel Stephen E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;N Engl J Med,2000

2. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease;Lancet,2003

3. The multiple actions of angiotensin II in atherosclerosis;Schmidt-Ott;Regul Pept,2000

4. Renin-angiotensin system and atherothrombotic disease;Rader;Arch Intern Med,2003

5. The effects of nonselective non-aspirin nonsteroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin;Kimmel;J Am Coll Cardiol,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of lipophilicity to the clinical effects of drugs;Russian Journal of Cardiology;2024-04-17

2. Co-administration of haloperidol and drugs affecting the angiotensin pathway: effect on the extrapyramidal system;Toxicology Mechanisms and Methods;2011-11-11

3. Estrategias adecuadas en la enfermedad cardiovascular. Los pacientes de alto riesgo;Medicina Clínica;2009-07

4. Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells;Biochemical and Biophysical Research Communications;2009-03

5. Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension;American Journal of Health-System Pharmacy;2007-06-01